Literature DB >> 18466762

ROCK, PAK, and Toll of synapses in Alzheimer's disease.

Antero Salminen1, Tiina Suuronen, Kai Kaarniranta.   

Abstract

Alzheimer's disease is a neurodegenerative disorder where the cognitive deficit is the hallmark symptom reflecting the progression of the disease. Synaptic dysfunction is a sensitive parameter of the AD pathology. Rho GTPases and the Rho kinases, ROCK1/2, and PAK1-3, are important regulators of synaptic plasticity, especially in maintaining the actin cytoskeleton of dendritic spines. Recent studies have revealed that beta-amyloid oligomers can inhibit PAK and stimulate ROCK-mediated signaling. Both of these effects enhance the disassembly of synaptic actin filaments and ultimately evoke synaptic loss. Brain tissue in AD recognizes the beta-amyloid peptide oligomers as foreign protein particles and mounts an inflammatory defense via Toll-like receptor (TLR) signaling which causes synaptic impairment. We will review here the dysfunction of ROCK, PAK, and Toll signaling associated with AD pathology. The protection of synapses in AD may provide new therapeutic approaches to combatting the cognitive impairment in AD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18466762     DOI: 10.1016/j.bbrc.2008.04.148

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  23 in total

1.  PAK inactivation impairs social recognition in 3xTg-AD Mice without increasing brain deposition of tau and Aβ.

Authors:  Dany Arsenault; Alexandre Dal-Pan; Cyntia Tremblay; David A Bennett; Matthieu J Guitton; Yves De Koninck; Susumu Tonegawa; Frédéric Calon
Journal:  J Neurosci       Date:  2013-06-26       Impact factor: 6.167

Review 2.  Rho-kinase: regulation, (dys)function, and inhibition.

Authors:  Ehsan Amin; Badri Nath Dubey; Si-Cai Zhang; Lothar Gremer; Radovan Dvorsky; Jens M Moll; Mohamed S Taha; Luitgard Nagel-Steger; Roland P Piekorz; Avril V Somlyo; Mohammad R Ahmadian
Journal:  Biol Chem       Date:  2013-11       Impact factor: 3.915

Review 3.  Long-term depression: a cell biological view.

Authors:  Morgan Sheng; Ali Ertürk
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-12-02       Impact factor: 6.237

4.  Analyses of the similarity and difference of global gene expression profiles in cortex regions of three neurodegenerative diseases: sporadic Creutzfeldt-Jakob disease (sCJD), fatal familial insomnia (FFI), and Alzheimer's disease (AD).

Authors:  Chan Tian; Di Liu; Wei Xiang; Hans A Kretzschmar; Qing-Lan Sun; Chen Gao; Yin Xu; Hui Wang; Xue-Yu Fan; Ge Meng; Wei Li; Xiao-Ping Dong
Journal:  Mol Neurobiol       Date:  2014-06-07       Impact factor: 5.590

Review 5.  Isoprenoids, small GTPases and Alzheimer's disease.

Authors:  Gero P Hooff; W Gibson Wood; Walter E Müller; Gunter P Eckert
Journal:  Biochim Biophys Acta       Date:  2010-04-08

Review 6.  Review: disruption of the postsynaptic density in Alzheimer's disease and other neurodegenerative dementias.

Authors:  Yuesong Gong; Carol F Lippa
Journal:  Am J Alzheimers Dis Other Demen       Date:  2010-09-21       Impact factor: 2.035

7.  Signaling through Rho GTPase pathway as viable drug target.

Authors:  Qun Lu; Frank M Longo; Huchen Zhou; Stephen M Massa; Yan-Hua Chen
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

8.  The overexpression of P21-activated kinase 5 (PAK5) promotes paclitaxel-chemoresistance of epithelial ovarian cancer.

Authors:  Diyou Li; Xiaohong Yao; Ping Zhang
Journal:  Mol Cell Biochem       Date:  2013-07-23       Impact factor: 3.396

9.  The protection of acetylcholinesterase inhibitor on β-amyloid-induced the injury of neurite outgrowth via regulating axon guidance related genes expression in neuronal cells.

Authors:  Jiao-Ning Shen; Deng-Shun Wang; Rui Wang
Journal:  Int J Clin Exp Pathol       Date:  2012-10-20

10.  PAK in Alzheimer disease, Huntington disease and X-linked mental retardation.

Authors:  Qiu-Lan Ma; Fusheng Yang; Sally A Frautschy; Greg M Cole
Journal:  Cell Logist       Date:  2012-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.